首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
Prevalence, persistence, and severity of 12-month and 30-day DSM-5 disorders in the World Mental Health Hong Kong Study 香港世界精神卫生研究中12个月和30天DSM-5障碍的患病率、持续性和严重程度
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lanwpc.2025.101757
Corine S.M. Wong , Candi M.C. Leung , Shiyi Wu , Francis P. Flores , Yoona Kim , Xiao Xiao , Solomon B.K. Wong , Wing Chung Chang , Wai Chi Chan , Nancy Xiaonan Yu , Calvin P.W. Cheng , Albert K.K. Chung , Edwin H.M. Lee , Wai Tat Chiu , William G. Axinn , Ronald C. Kessler , Michael Y. Ni

Background

The World Mental Health Hong Kong (WMHHK) Study aims to estimate 12-month and 30-day prevalence, persistence, severity, and correlates of DSM-5 anxiety, mood, and externalising disorders in Hong Kong, a densely populated city impacted by consecutive population-level stressors, including social unrest and the COVID-19 pandemic.

Methods

Face-to-face interviews, either in-person or video-based online, were conducted from November 2022 to March 2024 with a population-representative sample of 3053 adults aged 18 years and above. Diagnostic assessment utilised the World Mental Health Composite International Diagnostic Interview for DSM-5 (CIDI-5), evaluating ten mental disorders: anxiety (panic disorder, generalised anxiety disorder, post-traumatic stress disorder, obsessive-compulsive and related disorders), mood (major depressive disorder, persistent depressive disorder, bipolar spectrum disorders), and externalising (intermittent explosive disorder, alcohol use disorder, substance use disorder) disorders. Persistence was defined as 12-month prevalence among lifetime cases and 30-day prevalence among 12-month cases. Sociodemographic correlates were analysed using multivariable logistic regression.

Findings

Twelve-month and 30-day prevalence of any DSM-5 mental disorder were 10.6% (95% CI: 9.5–11.8) and 7.8% (95% CI: 6.7–8.9), respectively. Twelve-month prevalence was highest for anxiety disorders (8.0%, 95% CI: 7.1–8.9), followed by mood (4.3%, 95% CI: 3.4–5.2) and externalising (1.7%, 95% CI: 0.9–2.4) disorders. Twelve-month persistence among lifetime cases was 49.0%, overall and higher for anxiety (55.6%) than mood (39.0%) or externalising (35.3%) disorders. Younger and middle-aged adults, and who were not currently married, had elevated risks, while lower education was associated with greater disorder severity. Comorbidity was associated with increased persistence and severity across disorders.

Interpretation

This study shows a substantial mental health burden in Hong Kong during the post-pandemic period, highlighting the need for tailored public mental health programmes to address urban stressors in this unique context.

Funding

WYNG Foundation, Hong Kong; State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong Special Administrative Region, China; Hong Kong Jockey Club Charities Trust.
香港世界精神卫生(WMHHK)研究旨在评估香港人口密集城市中DSM-5焦虑、情绪和外化障碍的12个月和30天患病率、持续性、严重程度及其相关因素,香港是一个连续受到人口水平压力因素影响的城市,包括社会动荡和COVID-19大流行。方法:从2022年11月至2024年3月,对3053名18岁及以上的成年人进行了面对面或在线视频访谈。诊断评估使用了DSM-5的世界精神卫生综合国际诊断访谈(CIDI-5),评估了十种精神障碍:焦虑(恐慌障碍、广泛性焦虑障碍、创伤后应激障碍、强迫症及相关障碍)、情绪(重度抑郁症、持续性抑郁症、双相情感障碍)和外化(间歇性爆炸性障碍、酒精使用障碍、物质使用障碍)障碍。持续性定义为终生病例中12个月的患病率和12个月病例中30天的患病率。使用多变量逻辑回归分析社会人口学相关因素。发现任何DSM-5精神障碍的12个月和30天患病率分别为10.6% (95% CI: 9.5-11.8)和7.8% (95% CI: 6.7-8.9)。焦虑症的12个月患病率最高(8.0%,95% CI: 7.1-8.9),其次是情绪障碍(4.3%,95% CI: 3.4-5.2)和外化障碍(1.7%,95% CI: 0.9-2.4)。终生病例的12个月持续性为49.0%,总体而言,焦虑(55.6%)高于情绪(39.0%)或外化(35.3%)障碍。年轻人和中年人以及目前未婚的人患此病的风险较高,而受教育程度较低的人患此病的严重程度也较高。共病与疾病的持续性和严重程度增加有关。这项研究显示,香港在大流行后的时期,精神健康负担沉重,强调有必要制定有针对性的公共精神健康计划,以应对这一独特背景下的城市压力。fundingwing基金会,香港;香港大学脑与认知科学国家重点实验室,香港特别行政区;香港赛马会慈善信托基金
{"title":"Prevalence, persistence, and severity of 12-month and 30-day DSM-5 disorders in the World Mental Health Hong Kong Study","authors":"Corine S.M. Wong ,&nbsp;Candi M.C. Leung ,&nbsp;Shiyi Wu ,&nbsp;Francis P. Flores ,&nbsp;Yoona Kim ,&nbsp;Xiao Xiao ,&nbsp;Solomon B.K. Wong ,&nbsp;Wing Chung Chang ,&nbsp;Wai Chi Chan ,&nbsp;Nancy Xiaonan Yu ,&nbsp;Calvin P.W. Cheng ,&nbsp;Albert K.K. Chung ,&nbsp;Edwin H.M. Lee ,&nbsp;Wai Tat Chiu ,&nbsp;William G. Axinn ,&nbsp;Ronald C. Kessler ,&nbsp;Michael Y. Ni","doi":"10.1016/j.lanwpc.2025.101757","DOIUrl":"10.1016/j.lanwpc.2025.101757","url":null,"abstract":"<div><h3>Background</h3><div>The World Mental Health Hong Kong (WMHHK) Study aims to estimate 12-month and 30-day prevalence, persistence, severity, and correlates of DSM-5 anxiety, mood, and externalising disorders in Hong Kong, a densely populated city impacted by consecutive population-level stressors, including social unrest and the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>Face-to-face interviews, either in-person or video-based online, were conducted from November 2022 to March 2024 with a population-representative sample of 3053 adults aged 18 years and above. Diagnostic assessment utilised the World Mental Health Composite International Diagnostic Interview for DSM-5 (CIDI-5), evaluating ten mental disorders: anxiety (panic disorder, generalised anxiety disorder, post-traumatic stress disorder, obsessive-compulsive and related disorders), mood (major depressive disorder, persistent depressive disorder, bipolar spectrum disorders), and externalising (intermittent explosive disorder, alcohol use disorder, substance use disorder) disorders. Persistence was defined as 12-month prevalence among lifetime cases and 30-day prevalence among 12-month cases. Sociodemographic correlates were analysed using multivariable logistic regression.</div></div><div><h3>Findings</h3><div>Twelve-month and 30-day prevalence of any DSM-5 mental disorder were 10.6% (95% CI: 9.5–11.8) and 7.8% (95% CI: 6.7–8.9), respectively. Twelve-month prevalence was highest for anxiety disorders (8.0%, 95% CI: 7.1–8.9), followed by mood (4.3%, 95% CI: 3.4–5.2) and externalising (1.7%, 95% CI: 0.9–2.4) disorders. Twelve-month persistence among lifetime cases was 49.0%, overall and higher for anxiety (55.6%) than mood (39.0%) or externalising (35.3%) disorders. Younger and middle-aged adults, and who were not currently married, had elevated risks, while lower education was associated with greater disorder severity. Comorbidity was associated with increased persistence and severity across disorders.</div></div><div><h3>Interpretation</h3><div>This study shows a substantial mental health burden in Hong Kong during the post-pandemic period, highlighting the need for tailored public mental health programmes to address urban stressors in this unique context.</div></div><div><h3>Funding</h3><div><span>WYNG Foundation</span>, Hong Kong; <span>State Key Laboratory of Brain and Cognitive Sciences</span>, The <span>University of Hong Kong</span>, Hong Kong Special Administrative Region, China; <span>Hong Kong Jockey Club Charities Trust</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101757"},"PeriodicalIF":8.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145615787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From process to publication: the conduct and reporting of co-design in health research in the Western Pacific region 从程序到出版:西太平洋区域卫生研究共同设计的开展和报告
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lanwpc.2025.101766
Yaqoot Fatima , Michelle Olaithe , Shannon Edmed , Bushra Nasir
{"title":"From process to publication: the conduct and reporting of co-design in health research in the Western Pacific region","authors":"Yaqoot Fatima ,&nbsp;Michelle Olaithe ,&nbsp;Shannon Edmed ,&nbsp;Bushra Nasir","doi":"10.1016/j.lanwpc.2025.101766","DOIUrl":"10.1016/j.lanwpc.2025.101766","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101766"},"PeriodicalIF":8.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal trends in sepsis hospitalisations and mortality in Aotearoa New Zealand, 2000–2019: a population-based study 2000-2019年新西兰奥特罗阿败血症住院和死亡率的时间趋势:一项基于人群的研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lanwpc.2025.101767
Sharla McTavish , Jane Zhang , June Atkinson , Amanda Kvalsivg , Alice Hyun Min Kim , Colin McArthur , Paul Huggan , Michael G. Baker

Background

Globally, sepsis remains a substantial public health concern. To inform policy development and interventions for sepsis prevention, treatment, and surveillance in Aotearoa New Zealand (Aotearoa), we describe population-level epidemiological trends in hospitalised sepsis and mortality over two decades by major sociodemographic characteristics.

Methods

We undertook a retrospective, population-based descriptive study of all sepsis-associated hospitalisation (SAH) in Aotearoa between 2000 and 2019 using previously published case identification strategies and International Classification of Diseases, Tenth Revision (ICD-10) codes to identify SAHs in the National Minimum Dataset. Incidence and mortality rates, and case fatality risks were calculated along with analyses of trends over the 20-year observation period. Rate estimates were standardised to the age structure of the total population identified in the 2018 New Zealand Census.

Findings

We identified 266,105 unique SAH cases and 27,402 associated deaths, with an average age-standardised incidence rate (ASIR) of 320.4 admissions per 100,000 population and an age-standardised mortality rate (ASMR) of 34.2 deaths per 100,000 population. An average annual ASIR increase of 4.5% was observed, from 217.3 admissions in 2000 to 386.9 admissions per 100,000 population in 2019. ASMR decreased annually from 37.1 deaths in 2000 to 31.3 deaths per 100,000 population in 2019. Case fatality risk decreased from 15.9 deaths in 2000 to 8.1 deaths per 100 admissions in 2019, primarily driven by improvements in patient survival in ≥40-year age groups. Significant SAH incidence and mortality disparities were observed between patient populations, particularly by age, ethnicity and socioeconomic deprivation. Māori and Pacific Peoples had SAH incidence rates that were 1.7 and 2.3 times, respectively, higher than those of NMPA ethnicity, and had mortality rates that were 1.6 and 1.7 times higher. Similarly, those living in areas of high socioeconomic deprivation were twice as likely to develop SAH, and their SAH mortality rate was twice as high as that of those living in areas of the least socioeconomic deprivation.

Interpretation

Sepsis is common in Aotearoa and makes a substantial contribution to population mortality. Significant variation in incidence and mortality rate estimates was observed between patient populations, with higher rates in those <1 year and ≥70 years, of Māori or Pacific ethnicity, and those living in areas of high socioeconomic deprivation. Our findings highlight the burden of SAH and the need for targeted interventions to address sepsis prevention, surveillance and support for sepsis survivors in Aotearoa.

Funding

Health Research Council of New Zealand.
在全球范围内,败血症仍然是一个重大的公共卫生问题。为了为新西兰奥特罗阿(奥特罗阿)败血症预防、治疗和监测的政策制定和干预提供信息,我们通过主要的社会人口学特征描述了20年来住院败血症和死亡率的人口水平流行病学趋势。方法采用先前公布的病例识别策略和国际疾病分类第十版(ICD-10)代码,对2000年至2019年期间澳大利亚所有败血症相关住院(SAH)进行了一项回顾性、基于人群的描述性研究,以识别国家最低数据集中的SAH。计算了发病率和死亡率以及病死率风险,并对20年观察期的趋势进行了分析。比率估计是根据2018年新西兰人口普查中确定的总人口年龄结构进行标准化的。研究结果:我们确定了266105例独特的SAH病例和27402例相关死亡,平均年龄标准化发病率(ASIR)为每10万人320.4例入院,年龄标准化死亡率(ASMR)为每10万人34.2例死亡。ASIR平均每年增长4.5%,从2000年的每10万人217.3人增加到2019年的每10万人386.9人。ASMR每年从2000年的每10万人37.1例死亡下降到2019年的每10万人31.3例死亡。病死率风险从2000年的15.9例死亡下降到2019年的8.1例死亡,这主要是由于≥40岁年龄组患者生存率的提高。SAH的发病率和死亡率在患者人群中存在显著差异,特别是在年龄、种族和社会经济剥夺方面。Māori和太平洋民族的SAH发病率分别是NMPA族裔的1.7倍和2.3倍,死亡率是NMPA族裔的1.6倍和1.7倍。同样,生活在社会经济高度贫困地区的人患SAH的可能性是生活在社会经济最贫困地区的人的两倍,他们的SAH死亡率是生活在社会经济最贫困地区的人的两倍。脓毒症在澳大利亚很常见,是造成人口死亡的主要原因。患者群体之间的发病率和死亡率估计值存在显著差异,在1岁和≥70岁、Māori或太平洋族裔以及生活在高度社会经济贫困地区的患者中,发病率较高。我们的研究结果强调了SAH的负担和有针对性的干预措施的必要性,以解决败血症预防、监测和支持败血症幸存者。新西兰卫生研究理事会。
{"title":"Temporal trends in sepsis hospitalisations and mortality in Aotearoa New Zealand, 2000–2019: a population-based study","authors":"Sharla McTavish ,&nbsp;Jane Zhang ,&nbsp;June Atkinson ,&nbsp;Amanda Kvalsivg ,&nbsp;Alice Hyun Min Kim ,&nbsp;Colin McArthur ,&nbsp;Paul Huggan ,&nbsp;Michael G. Baker","doi":"10.1016/j.lanwpc.2025.101767","DOIUrl":"10.1016/j.lanwpc.2025.101767","url":null,"abstract":"<div><h3>Background</h3><div>Globally, sepsis remains a substantial public health concern. To inform policy development and interventions for sepsis prevention, treatment, and surveillance in Aotearoa New Zealand (Aotearoa), we describe population-level epidemiological trends in hospitalised sepsis and mortality over two decades by major sociodemographic characteristics.</div></div><div><h3>Methods</h3><div>We undertook a retrospective, population-based descriptive study of all sepsis-associated hospitalisation (SAH) in Aotearoa between 2000 and 2019 using previously published case identification strategies and <em>International Classification of Diseases, Tenth Revision</em> (ICD-10) codes to identify SAHs in the National Minimum Dataset. Incidence and mortality rates, and case fatality risks were calculated along with analyses of trends over the 20-year observation period. Rate estimates were standardised to the age structure of the total population identified in the 2018 New Zealand Census.</div></div><div><h3>Findings</h3><div>We identified 266,105 unique SAH cases and 27,402 associated deaths, with an average age-standardised incidence rate (ASIR) of 320.4 admissions per 100,000 population and an age-standardised mortality rate (ASMR) of 34.2 deaths per 100,000 population. An average annual ASIR increase of 4.5% was observed, from 217.3 admissions in 2000 to 386.9 admissions per 100,000 population in 2019. ASMR decreased annually from 37.1 deaths in 2000 to 31.3 deaths per 100,000 population in 2019. Case fatality risk decreased from 15.9 deaths in 2000 to 8.1 deaths per 100 admissions in 2019, primarily driven by improvements in patient survival in ≥40-year age groups. Significant SAH incidence and mortality disparities were observed between patient populations, particularly by age, ethnicity and socioeconomic deprivation. Māori and Pacific Peoples had SAH incidence rates that were 1.7 and 2.3 times, respectively, higher than those of NMPA ethnicity, and had mortality rates that were 1.6 and 1.7 times higher. Similarly, those living in areas of high socioeconomic deprivation were twice as likely to develop SAH, and their SAH mortality rate was twice as high as that of those living in areas of the least socioeconomic deprivation.</div></div><div><h3>Interpretation</h3><div>Sepsis is common in Aotearoa and makes a substantial contribution to population mortality. Significant variation in incidence and mortality rate estimates was observed between patient populations, with higher rates in those &lt;1 year and ≥70 years, of Māori or Pacific ethnicity, and those living in areas of high socioeconomic deprivation. Our findings highlight the burden of SAH and the need for targeted interventions to address sepsis prevention, surveillance and support for sepsis survivors in Aotearoa.</div></div><div><h3>Funding</h3><div><span>Health Research Council</span> of New Zealand.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101767"},"PeriodicalIF":8.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping the landscape of healthcare-associated infections in China, 2015–2019: a nation-wide observational study 绘制2015-2019年中国医疗保健相关感染的景观:一项全国性的观察性研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-01 DOI: 10.1016/j.lanwpc.2025.101775
Hong-Wu Yao , Chen-Long Lv , Yao Tian , Yu-Zheng Zhang , Zheng-Hao Yu , Ming-Mei Du , Cheng-Xue Ma , Ji-Jiang Suo , Shuo Zhao , Yu Zhang , Yu-Bin Xing , An-Ran Zhang , Yan-Ling Bai , Bo-Wei Liu , Zhong-Qiang Yan , Ju-Yuan Liu , Meng Cai , Rui Huo , Jian Lin , Chun-Ping Chen , Yun-Xi Liu

Background

Healthcare-associated infections (HAIs), complicated by antimicrobial resistance continue to affect all countries with unprecedented threat, especially for developing countries. Our objective was to explore the epidemiological features, spatiotemporal heterogeneity and associated factors of HAIs and HAI related multi-drug resistant organisms (MDROs) in China.

Methods

We used national surveillance data that were collected from 6867 sampled hospitals during 2015–2019 to determine the annual incidence of HAIs, key HAI-related quality indicators and associated factors.

Findings

During 2015–2019, total of 4,959,230 HAIs were reported in sampled hospitals in China, with the overall incidence and prevalence estimated as 1.1 and 2.3 per 100 inpatients, which showed decline trend over time. Carbapenem-resistant Acinetobacter baumannii (CRAB) had the highest overall detection rate (51.1%), followed by methicillin-resistant Staphylococcus aureus (MRSA) (31.0%), carbapenem-resistant Pseudomonas aeruginosa (CRPA) (22.8%), and carbapenem-resistant Klebsiella pneumonia (CRKP) (12.4%). Detection rates of MRSA, carbapenem-resistant Escherichia coli (CREC), and vancomycin-resistant Enterococcus faecium (VREfm) reduced, in contrast with an increasing trend for CRKP. Higher risk of HAIs was associated with hospitals located in urban areas (incidence rate ratio [IRR]: 1.39, p < 0.001), in regions with higher GDP per capita (IRR: 1.03, p < 0.001), with more beds (IRR: 1.64 and 2.16 for 500−1500 and ≥ 1500 beds respectively, p < 0.001), as well as in south region of China (IRR: 1.23, p < 0.001). The reduced annual rates of HAIs were observed after 2017 (IRR: 0.92, p < 0.001), when 12 new standards targeted for HAIs were implemented.

Interpretation

The study increases the understanding of HAIs and antimicrobial resistance. It highlights high-risk areas of HAIs and MDROs of concern, where targeted measures to continuously enhance management and policies implementation of HAIs are needed.

Funding

The Foundation of State Key Laboratory of Pathogen and Biosecurity of China (Grant No. SKLPBS2443) and Infection Prevention and Control Research Project of “Gan·Dong China” (Grant No. GY2023022-A).
卫生保健相关感染,连同抗菌素耐药性,继续对所有国家造成前所未有的威胁,特别是对发展中国家。目的探讨中国HAI及其相关多重耐药菌(MDROs)的流行病学特征、时空异质性及相关因素。方法利用2015-2019年全国6867家抽样医院的监测数据,确定hai的年发病率、关键质量指标及相关因素。2015-2019年,中国抽样医院共报告HAIs 4,959,230例,总体发病率和患病率分别为1.1 / 100和2.3 / 100,随着时间的推移呈下降趋势。耐碳青霉烯鲍曼不动杆菌(CRAB)总检出率最高(51.1%),其次是耐甲氧西林金黄色葡萄球菌(MRSA)(31.0%)、耐碳青霉烯铜绿假单胞菌(CRPA)(22.8%)和耐碳青霉烯肺炎克雷伯菌(CRKP)(12.4%)。MRSA、耐碳青霉烯类大肠杆菌(CREC)和耐万古霉素类屎肠球菌(VREfm)的检出率下降,而CRKP的检出率呈上升趋势。城市地区(发病率比[IRR]: 1.39, p < 0.001)、人均GDP较高的地区(IRR: 1.03, p < 0.001)、床位较多的地区(500 - 1500和≥1500床位的IRR分别为1.64和2.16,p < 0.001)以及中国南方地区(IRR: 1.23, p < 0.001)的医院发生HAIs的风险较高。2017年实施了12项针对HAIs的新标准后,观察到HAIs的年发生率降低(IRR: 0.92, p < 0.001)。本研究增加了对HAIs与抗菌药物耐药性的认识。报告强调了令人关注的卫生保健机构和卫生保健机构的高风险领域,在这些领域需要采取有针对性的措施,不断加强卫生保健机构的管理和政策执行。病原与生物安全国家重点实验室资助项目(批准号:2018102239902);SKLPBS2443)和“赣·东中国”感染防治研究项目(批准号:GY2023022-A)。
{"title":"Mapping the landscape of healthcare-associated infections in China, 2015–2019: a nation-wide observational study","authors":"Hong-Wu Yao ,&nbsp;Chen-Long Lv ,&nbsp;Yao Tian ,&nbsp;Yu-Zheng Zhang ,&nbsp;Zheng-Hao Yu ,&nbsp;Ming-Mei Du ,&nbsp;Cheng-Xue Ma ,&nbsp;Ji-Jiang Suo ,&nbsp;Shuo Zhao ,&nbsp;Yu Zhang ,&nbsp;Yu-Bin Xing ,&nbsp;An-Ran Zhang ,&nbsp;Yan-Ling Bai ,&nbsp;Bo-Wei Liu ,&nbsp;Zhong-Qiang Yan ,&nbsp;Ju-Yuan Liu ,&nbsp;Meng Cai ,&nbsp;Rui Huo ,&nbsp;Jian Lin ,&nbsp;Chun-Ping Chen ,&nbsp;Yun-Xi Liu","doi":"10.1016/j.lanwpc.2025.101775","DOIUrl":"10.1016/j.lanwpc.2025.101775","url":null,"abstract":"<div><h3>Background</h3><div>Healthcare-associated infections (HAIs), complicated by antimicrobial resistance continue to affect all countries with unprecedented threat, especially for developing countries. Our objective was to explore the epidemiological features, spatiotemporal heterogeneity and associated factors of HAIs and HAI related multi-drug resistant organisms (MDROs) in China.</div></div><div><h3>Methods</h3><div>We used national surveillance data that were collected from 6867 sampled hospitals during 2015–2019 to determine the annual incidence of HAIs, key HAI-related quality indicators and associated factors.</div></div><div><h3>Findings</h3><div>During 2015–2019, total of 4,959,230 HAIs were reported in sampled hospitals in China, with the overall incidence and prevalence estimated as 1.1 and 2.3 per 100 inpatients, which showed decline trend over time. Carbapenem-resistant <em>Acinetobacter baumannii</em> (CRAB) had the highest overall detection rate (51.1%), followed by methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) (31.0%), carbapenem-resistant <em>Pseudomonas aeruginosa</em> (CRPA) (22.8%), and carbapenem-resistant <em>Klebsiella pneumonia</em> (CRKP) (12.4%). Detection rates of MRSA, carbapenem-resistant <em>Escherichia coli</em> (CREC), and vancomycin-resistant <em>Enterococcus faecium</em> (VREfm) reduced, in contrast with an increasing trend for CRKP. Higher risk of HAIs was associated with hospitals located in urban areas (incidence rate ratio [IRR]: 1.39, p &lt; 0.001), in regions with higher GDP per capita (IRR: 1.03, p &lt; 0.001), with more beds (IRR: 1.64 and 2.16 for 500−1500 and ≥ 1500 beds respectively, p &lt; 0.001), as well as in south region of China (IRR: 1.23, p &lt; 0.001). The reduced annual rates of HAIs were observed after 2017 (IRR: 0.92, p &lt; 0.001), when 12 new standards targeted for HAIs were implemented.</div></div><div><h3>Interpretation</h3><div>The study increases the understanding of HAIs and antimicrobial resistance. It highlights high-risk areas of HAIs and MDROs of concern, where targeted measures to continuously enhance management and policies implementation of HAIs are needed.</div></div><div><h3>Funding</h3><div><span>The Foundation of State Key Laboratory of Pathogen and Biosecurity of China</span> (Grant No. <span><span>SKLPBS2443</span></span>) and <span>Infection Prevention and Control Research Project of “Gan·Dong China”</span> (Grant No. <span><span>GY2023022-A</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101775"},"PeriodicalIF":8.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145789940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic evaluation of potential national childhood screening strategies for type 1 diabetes in Australia 澳大利亚1型糖尿病潜在国家儿童筛查策略的经济评价
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-21 DOI: 10.1016/j.lanwpc.2025.101755
Winnie Chen , Kirsten Howard , Sarah Norris , Natasha Nassar , Maria E. Craig , Kirstine J. Bell

Background

Type 1 diabetes (T1D) is an autoimmune condition affecting children. We aimed to investigate the costs and cost-effectiveness of potential national childhood screening strategies for T1D compared to no screening (usual care).

Methods

Screening costs were obtained from trial-based estimates. A Markov microsimulation model was developed to identify the most cost-effective childhood T1D screening strategy. The three screening strategies modelled were: Strategy 1) newborn genetic risk-stratification with bloodspot sampling, followed by autoantibody screening in at-risk children; Strategy 2) infant genetic risk-stratification using saliva sampling, followed by autoantibody screening in at-risk children; Strategy 3) population-wide autoantibody screening at two childhood ages. The model tracked 100,000 individuals from birth to 30 years of age. One-way and probabilistic sensitivity analyses were conducted.

Findings

Newborn bloodspot genetic risk-stratified screening (strategy 1) was the most cost-effective strategy. Incremental cost-effectiveness ratios (ICERs) were $50,682 per quality-adjusted life year (QALY) gained for strategy 1, $85,440 per QALY gained for strategy 2, and $133,285 per QALY gained for strategy 3. In the optimal strategy (strategy 1), the cost was $480,798 per screen-detected T1D and $12,183 per episode of diabetic ketoacidosis avoided. Results were sensitive to changes in time horizon, discount rates, and cost of the screening tests.

Interpretation

Of the three modelled T1D screening strategies, newborn bloodspot genetic risk-stratified screening was the most cost-effective. Varying cost inputs may change this hierarchy. Our economic evaluation will be useful for informing future T1D childhood screening policy in Australia and other high-income countries.

Funding

JDRF Australia.
背景1型糖尿病(T1D)是一种影响儿童的自身免疫性疾病。我们的目的是调查与不筛查(常规护理)相比,潜在的国家儿童T1D筛查策略的成本和成本效益。方法筛选成本由基于试验的估计得出。建立了一个马尔可夫微观模拟模型,以确定最具成本效益的儿童T1D筛查策略。建模的三种筛查策略为:策略1)新生儿遗传风险分层,采用血点取样,然后对高危儿童进行自身抗体筛查;策略2)利用唾液取样进行婴儿遗传风险分层,然后对高危儿童进行自身抗体筛查;策略3)在两个儿童期进行全人群自身抗体筛查。该模型追踪了10万人从出生到30岁的情况。进行了单向和概率敏感性分析。结果新生儿血斑遗传风险分层筛查(策略1)是最具成本效益的策略。策略1每个质量调整生命年(QALY)增加的增量成本效益比(ICERs)为50,682美元,策略2每个质量调整生命年增加的增量成本效益比为85,440美元,策略3每个质量调整生命年增加的增量成本效益比为133,285美元。在最佳策略(策略1)中,每个筛查检测到的T1D的成本为480,798美元,每个避免糖尿病酮症酸中毒发作的成本为12,183美元。结果对筛选试验的时间范围、贴现率和成本的变化很敏感。在三种模拟的T1D筛查策略中,新生儿血斑遗传风险分层筛查是最具成本效益的。不同的成本投入可能会改变这种层次结构。我们的经济评估将为澳大利亚和其他高收入国家未来的T1D儿童筛查政策提供有用的信息。FundingJDRF澳大利亚。
{"title":"Economic evaluation of potential national childhood screening strategies for type 1 diabetes in Australia","authors":"Winnie Chen ,&nbsp;Kirsten Howard ,&nbsp;Sarah Norris ,&nbsp;Natasha Nassar ,&nbsp;Maria E. Craig ,&nbsp;Kirstine J. Bell","doi":"10.1016/j.lanwpc.2025.101755","DOIUrl":"10.1016/j.lanwpc.2025.101755","url":null,"abstract":"<div><h3>Background</h3><div>Type 1 diabetes (T1D) is an autoimmune condition affecting children. We aimed to investigate the costs and cost-effectiveness of potential national childhood screening strategies for T1D compared to no screening (usual care).</div></div><div><h3>Methods</h3><div>Screening costs were obtained from trial-based estimates. A Markov microsimulation model was developed to identify the most cost-effective childhood T1D screening strategy. The three screening strategies modelled were: Strategy 1) newborn genetic risk-stratification with bloodspot sampling, followed by autoantibody screening in at-risk children; Strategy 2) infant genetic risk-stratification using saliva sampling, followed by autoantibody screening in at-risk children; Strategy 3) population-wide autoantibody screening at two childhood ages. The model tracked 100,000 individuals from birth to 30 years of age. One-way and probabilistic sensitivity analyses were conducted.</div></div><div><h3>Findings</h3><div>Newborn bloodspot genetic risk-stratified screening (strategy 1) was the most cost-effective strategy. Incremental cost-effectiveness ratios (ICERs) were $50,682 per quality-adjusted life year (QALY) gained for strategy 1, $85,440 per QALY gained for strategy 2, and $133,285 per QALY gained for strategy 3. In the optimal strategy (strategy 1), the cost was $480,798 per screen-detected T1D and $12,183 per episode of diabetic ketoacidosis avoided. Results were sensitive to changes in time horizon, discount rates, and cost of the screening tests.</div></div><div><h3>Interpretation</h3><div>Of the three modelled T1D screening strategies, newborn bloodspot genetic risk-stratified screening was the most cost-effective. Varying cost inputs may change this hierarchy. Our economic evaluation will be useful for informing future T1D childhood screening policy in Australia and other high-income countries.</div></div><div><h3>Funding</h3><div>JDRF Australia.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101755"},"PeriodicalIF":8.1,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The changing epidemiology of syphilis: new strategies for new challenges in China 梅毒流行病学的变化:应对中国新挑战的新策略
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-21 DOI: 10.1016/j.lanwpc.2025.101752
Guiying Cao , Huang Jing , Cai Jie , Min Liu
Syphilis was nearly eliminated from China in the 1960s; however, it has resurgent and continued to spread in the country since the 1980s. Surveillance data from China revealed that the notification rate of syphilis increased 11.88% annually between 2004 and 2019, with an notification rate of 38.37 per 100,000 population in 2019. This paper aims to summarize the national policies and plans for syphilis since the 1980s; the full-cycle management strategy for the publicity and education, screening, diagnosis and treatment, management, and surveillance and monitoring of syphilis; the epidemiology of syphilis; and challenges in the prevention and control in China. Finally, we propose a series of new strategies to better manage syphilis to help eliminate the infection in China.
梅毒在20世纪60年代几乎从中国消灭;然而,自20世纪80年代以来,它已经复活并继续在该国蔓延。中国监测数据显示,2004年至2019年,梅毒通报率每年增长11.88%,2019年通报率为38.37 / 10万人。本文旨在总结20世纪80年代以来国家防治梅毒的政策和计划;梅毒的宣传教育、筛查诊疗、管理和监测监测全周期管理策略;梅毒流行病学;中国疫情防控面临的挑战。最后,我们提出了一系列新的策略来更好地管理梅毒,以帮助消除中国的感染。
{"title":"The changing epidemiology of syphilis: new strategies for new challenges in China","authors":"Guiying Cao ,&nbsp;Huang Jing ,&nbsp;Cai Jie ,&nbsp;Min Liu","doi":"10.1016/j.lanwpc.2025.101752","DOIUrl":"10.1016/j.lanwpc.2025.101752","url":null,"abstract":"<div><div>Syphilis was nearly eliminated from China in the 1960s; however, it has resurgent and continued to spread in the country since the 1980s. Surveillance data from China revealed that the notification rate of syphilis increased 11.88% annually between 2004 and 2019, with an notification rate of 38.37 per 100,000 population in 2019. This paper aims to summarize the national policies and plans for syphilis since the 1980s; the full-cycle management strategy for the publicity and education, screening, diagnosis and treatment, management, and surveillance and monitoring of syphilis; the epidemiology of syphilis; and challenges in the prevention and control in China. Finally, we propose a series of new strategies to better manage syphilis to help eliminate the infection in China.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101752"},"PeriodicalIF":8.1,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive epidemiological analysis of severe fever with thrombocytopenia syndrome in Japan, 2013–2023: descriptive observational study 2013-2023年日本发热伴血小板减少综合征综合流行病学分析:描述性观察性研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-21 DOI: 10.1016/j.lanwpc.2025.101747
Tomohiro Ohno , Hirofumi Kato , Yusuke Kobayashi , Masami Kitaoka , Minako Kanesaki , Shimpei Murai , Masaru Jinushi , Mitsuki Aoki , Takuri Takahashi , Tomoe Shimada , Taro Kamigaki , Tomimasa Sunagawa

Background

Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne zoonotic disease that poses a serious public health challenge in several Asian countries. In this study, we aimed to describe the recent epidemiological characteristics of SFTS in Japan using denominator-based test data.

Methods

We analysed reported SFTS case-patients in Japan using national surveillance data from March 2013 to April 2024. The case-fatality ratio (CFR) was calculated using the National Vital Statistics Surveillance System (NVSSS) for 2013–2022. Trends in test numbers and positivity rates were examined using data from annual reports and public health institute surveys.

Findings

During the study period, 931 case-patients were reported, including 11 veterinary healthcare workers. The annual notification rate rose from 3.12 per ten million in 2013 to 10.46 in 2023, with 30 (64%) estimated infection prefectures, primarily in western and central Japan. The NVSSS CFRs remained high at approximately 20%. Test numbers and positive results increased from 2013 (n = 350, n = 41) to 2022 (n = 923, n = 95); however, positivity decreased from 12% to 10%.

Interpretation

The annual SFTS notification rate increased, and infection regions expanded between 2013 and 2023, with persistently high CFRs and increased testing. Veterinary healthcare workers appear to be a potential high-risk group. These findings highlight that SFTS remains a public health concern in Japan, requiring a comprehensive health strategy.

Funding

This work was supported by the Japan Society for the Promotion of Science Kakenhi Grants-in-Aid for Young Scientists (grant number: 24K19277).
发热伴血小板减少综合征(SFTS)是一种蜱传人畜共患疾病,在一些亚洲国家构成了严重的公共卫生挑战。在本研究中,我们旨在利用基于分母的检测数据描述日本SFTS的最新流行病学特征。方法利用2013年3月至2024年4月日本国家监测数据,对报告的SFTS病例进行分析。使用2013-2022年国家生命统计监测系统(NVSSS)计算病死率(CFR)。使用年度报告和公共卫生研究所调查的数据检查了检测次数和阳性率的趋势。研究期间共报告病例931例,其中兽医卫生工作者11例。年通报率从2013年的每千万人3.12例上升到2023年的每千万人10.46例,估计有30个(64%)感染县,主要在日本西部和中部。NVSSS的cfr仍然很高,约为20%。检测数量和阳性结果从2013年(n = 350, n = 41)增加到2022年(n = 923, n = 95);然而,积极性从12%下降到10%。在2013年至2023年期间,SFTS年度报告率上升,感染区域扩大,持续高CFRs和增加检测。兽医保健工作者似乎是一个潜在的高风险群体。这些发现强调,在日本,SFTS仍然是一个公共卫生问题,需要一个全面的卫生战略。本研究由日本科学促进会Kakenhi青年科学家资助项目(资助号:24K19277)资助。
{"title":"Comprehensive epidemiological analysis of severe fever with thrombocytopenia syndrome in Japan, 2013–2023: descriptive observational study","authors":"Tomohiro Ohno ,&nbsp;Hirofumi Kato ,&nbsp;Yusuke Kobayashi ,&nbsp;Masami Kitaoka ,&nbsp;Minako Kanesaki ,&nbsp;Shimpei Murai ,&nbsp;Masaru Jinushi ,&nbsp;Mitsuki Aoki ,&nbsp;Takuri Takahashi ,&nbsp;Tomoe Shimada ,&nbsp;Taro Kamigaki ,&nbsp;Tomimasa Sunagawa","doi":"10.1016/j.lanwpc.2025.101747","DOIUrl":"10.1016/j.lanwpc.2025.101747","url":null,"abstract":"<div><h3>Background</h3><div>Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne zoonotic disease that poses a serious public health challenge in several Asian countries. In this study, we aimed to describe the recent epidemiological characteristics of SFTS in Japan using denominator-based test data.</div></div><div><h3>Methods</h3><div>We analysed reported SFTS case-patients in Japan using national surveillance data from March 2013 to April 2024. The case-fatality ratio (CFR) was calculated using the National Vital Statistics Surveillance System (NVSSS) for 2013–2022. Trends in test numbers and positivity rates were examined using data from annual reports and public health institute surveys.</div></div><div><h3>Findings</h3><div>During the study period, 931 case-patients were reported, including 11 veterinary healthcare workers. The annual notification rate rose from 3.12 per ten million in 2013 to 10.46 in 2023, with 30 (64%) estimated infection prefectures, primarily in western and central Japan. The NVSSS CFRs remained high at approximately 20%. Test numbers and positive results increased from 2013 (n = 350, n = 41) to 2022 (n = 923, n = 95); however, positivity decreased from 12% to 10%.</div></div><div><h3>Interpretation</h3><div>The annual SFTS notification rate increased, and infection regions expanded between 2013 and 2023, with persistently high CFRs and increased testing. Veterinary healthcare workers appear to be a potential high-risk group. These findings highlight that SFTS remains a public health concern in Japan, requiring a comprehensive health strategy.</div></div><div><h3>Funding</h3><div>This work was supported by the Japan Society for the Promotion of <span>Science Kakenhi</span> Grants-in-Aid for Young Scientists (grant number: <span><span>24K19277</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101747"},"PeriodicalIF":8.1,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-differences in the intergenerational transmission of mental disorders among schizophrenia probands: familial risk and protective factors in a population-based study 精神分裂症先证者精神障碍代际遗传的性别差异:一项基于人群的研究中的家族风险和保护因素
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-20 DOI: 10.1016/j.lanwpc.2025.101750
Zhi Sheng , Tianhang Zhou , Chunyu Du , Tingfang Wu , Liping Wen , Xianmei Yang , Wencai Chen , Xuehong Ma , Hua Deng , Ling Ge , Changchun Zhang , Xu Hong , Rui He , Xiangdong Du , Lingyan Zhu , Hu Xiang , Sijing Chen , Jiachen Liu , Yongzhuo Ding , Guangming Liang , Xin Yu

Background

Parental schizophrenia confers intergenerational mental health risks. The sex-specific transmission patterns remain poorly quantified. This study examined parent-reported transmission rate and familial risk factors among Chinese offspring of schizophrenia probands.

Methods

In this cross-sectional study, we enrolled 27,315 schizophrenia probands and 35,772 offspring. Psychiatric disorder diagnoses of offspring were parent-reported and subsequently verified via the medical management system. Age- and sex-standardized rate referenced China's 2020 census. Robust Poisson regression generated adjusted rate ratios (aRR). Multivariable logistic models were used to identify risk factors for young offspring. This study was registered with ClinicalTrials (NCT07005245).

Findings

The parent-reported transmission rate in offspring was 2.68% (95% CI, 2.52%–2.85%), dominated by schizophrenia spectrum disorders (1.42%). Standardized rates reached 2.53% (95% CI, 2.01%–3.05%) after demographic standardization. Offspring risk increased by 86.0% when conception occurred post-parental illness onset. Firstborn status (aRR = 1.67), low-income household (aRR = 1.43), and being a male child (aRR = 1.14) were significantly associated with elevated risk. Sex-specific parental age effects were also observed. In the subgroup analysis of underage (<17 years) offspring, maternal transmission was associated with post-parental-onset birth (OR = 2.48, p < 0.001), lower household income (OR = 2.32, p < 0.001), and prenatal antipsychotic exposure (OR = 1.69, p < 0.001). Paternal transmission was related to father-only caregiving (OR = 2.15, p < 0.001), lower household income (OR = 1.97, p < 0.001), and male offspring (OR = 1.79, p = 0.001). Dual-parent care demonstrated a robust protective effect across both maternal and paternal schizophrenia groups (OR = 0.75, 95% CI, 0.51–1.10).

Interpretation

Our findings highlighted critical interactions between familial aggregation, sex-differentiated perinatal exposures, and caregiving environments. Policy priorities should integrate sex-stratified genetic counselling, prenatal medication monitoring, and family support programs targeting caregiving inequalities.

Funding

This study was supported by the National Natural Science Foundation of China (32070589).
父母精神分裂症会带来代际心理健康风险。性别特异性传播模式的量化仍然很差。本研究考察了中国精神分裂症先证者后代中父母报告的传播率和家族危险因素。方法在这项横断面研究中,我们招募了27,315名精神分裂症先证者和35,772名后代。后代的精神障碍诊断由父母报告,随后通过医疗管理系统进行验证。年龄和性别标准化率参考了中国2020年人口普查数据。稳健泊松回归生成调整率比(aRR)。使用多变量逻辑模型来确定年轻后代的危险因素。本研究已在ClinicalTrials注册(NCT07005245)。结果父母报告的后代传播率为2.68% (95% CI, 2.52% ~ 2.85%),以精神分裂症谱系障碍(1.42%)为主。人口统计学标准化后,标准化率达到2.53% (95% CI, 2.01% ~ 3.05%)。当受孕发生在父母发病后,后代风险增加86.0%。长子身份(aRR = 1.67)、低收入家庭(aRR = 1.43)和男孩身份(aRR = 1.14)与风险升高显著相关。性别差异的父母年龄效应也被观察到。在未成年(17岁)后代的亚组分析中,母体传播与父母后发病分娩(OR = 2.48, p < 0.001)、较低的家庭收入(OR = 2.32, p < 0.001)和产前抗精神病药物暴露(OR = 1.69, p < 0.001)有关。父系遗传与仅由父亲照料(OR = 2.15, p < 0.001)、较低的家庭收入(OR = 1.97, p < 0.001)和男性后代(OR = 1.79, p = 0.001)有关。双亲护理在母亲和父亲精神分裂症组中都显示出强大的保护作用(OR = 0.75, 95% CI, 0.51-1.10)。解释:我们的研究结果强调了家族聚集、性别分化的围产期暴露和护理环境之间的关键相互作用。政策重点应包括按性别分层的遗传咨询、产前药物监测和针对照顾不平等的家庭支持计划。本研究由国家自然科学基金(32070589)资助。
{"title":"Sex-differences in the intergenerational transmission of mental disorders among schizophrenia probands: familial risk and protective factors in a population-based study","authors":"Zhi Sheng ,&nbsp;Tianhang Zhou ,&nbsp;Chunyu Du ,&nbsp;Tingfang Wu ,&nbsp;Liping Wen ,&nbsp;Xianmei Yang ,&nbsp;Wencai Chen ,&nbsp;Xuehong Ma ,&nbsp;Hua Deng ,&nbsp;Ling Ge ,&nbsp;Changchun Zhang ,&nbsp;Xu Hong ,&nbsp;Rui He ,&nbsp;Xiangdong Du ,&nbsp;Lingyan Zhu ,&nbsp;Hu Xiang ,&nbsp;Sijing Chen ,&nbsp;Jiachen Liu ,&nbsp;Yongzhuo Ding ,&nbsp;Guangming Liang ,&nbsp;Xin Yu","doi":"10.1016/j.lanwpc.2025.101750","DOIUrl":"10.1016/j.lanwpc.2025.101750","url":null,"abstract":"<div><h3>Background</h3><div>Parental schizophrenia confers intergenerational mental health risks. The sex-specific transmission patterns remain poorly quantified. This study examined parent-reported transmission rate and familial risk factors among Chinese offspring of schizophrenia probands.</div></div><div><h3>Methods</h3><div>In this cross-sectional study, we enrolled 27,315 schizophrenia probands and 35,772 offspring. Psychiatric disorder diagnoses of offspring were parent-reported and subsequently verified via the medical management system. Age- and sex-standardized rate referenced China's 2020 census. Robust Poisson regression generated adjusted rate ratios (aRR). Multivariable logistic models were used to identify risk factors for young offspring. This study was registered with ClinicalTrials (<span><span>NCT07005245</span><svg><path></path></svg></span>).</div></div><div><h3>Findings</h3><div>The parent-reported transmission rate in offspring was 2.68% (95% CI, 2.52%–2.85%), dominated by schizophrenia spectrum disorders (1.42%). Standardized rates reached 2.53% (95% CI, 2.01%–3.05%) after demographic standardization. Offspring risk increased by 86.0% when conception occurred post-parental illness onset. Firstborn status (aRR = 1.67), low-income household (aRR = 1.43), and being a male child (aRR = 1.14) were significantly associated with elevated risk. Sex-specific parental age effects were also observed. In the subgroup analysis of underage (&lt;17 years) offspring, maternal transmission was associated with post-parental-onset birth (OR = 2.48, <em>p</em> &lt; 0.001), lower household income (OR = 2.32, <em>p</em> &lt; 0.001), and prenatal antipsychotic exposure (OR = 1.69, <em>p</em> &lt; 0.001). Paternal transmission was related to father-only caregiving (OR = 2.15, <em>p</em> &lt; 0.001), lower household income (OR = 1.97, <em>p</em> &lt; 0.001), and male offspring (OR = 1.79, <em>p</em> = 0.001). Dual-parent care demonstrated a robust protective effect across both maternal and paternal schizophrenia groups (OR = 0.75, 95% CI, 0.51–1.10).</div></div><div><h3>Interpretation</h3><div>Our findings highlighted critical interactions between familial aggregation, sex-differentiated perinatal exposures, and caregiving environments. Policy priorities should integrate sex-stratified genetic counselling, prenatal medication monitoring, and family support programs targeting caregiving inequalities.</div></div><div><h3>Funding</h3><div>This study was supported by the <span>National Natural Science Foundation of China</span> (32070589).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101750"},"PeriodicalIF":8.1,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer survivorship in the Western Pacific: from differences to shared-goals and from challenges to opportunities 西太平洋地区的癌症幸存者:从差异到共同目标,从挑战到机遇
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-18 DOI: 10.1016/j.lanwpc.2025.101749
Raymond Javan Chan , Reegan Knowles , Carolyn Taylor , Nirmala Bhoo Pathy , Ke Yu , Karolina Lisy , Julia Lai-Kwon , Miyako Tsuchiya , Yan Lou , Wendy Lam , Michael Jefford
The Western Pacific region consists of 38 countries and approximately one quarter of the world population. Over 17 million people in the region have a personal history of cancer, necessitating effective survivorship care approaches for optimal outcomes and experiences. There are substantial differences in population and income and resource availability between countries within the region which impacts cancer survivorship care. Likewise, varying healthcare systems and models of survivorship care (e.g., primary care-led, patient-led etc.) affect the survivorship experience and outcome of people affected by cancer. Despite differences across Western Pacific countries, issues facing cancer survivors are similar, with shared challenges including lack of focus on survivorship care, adoption of a holistic approach, and workforce availability. Various approaches to cancer survivorship are being developed and implemented across the region, but a region-wide, coordinated approach is needed, involving thoughtful leadership and sharing of ideas to achieve better outcomes.
西太平洋区域由38个国家组成,约占世界人口的四分之一。该地区有超过1700万人有个人癌症病史,因此需要有效的生存护理方法来获得最佳结果和体验。本区域各国之间在人口、收入和资源可得性方面存在巨大差异,这影响到癌症幸存者护理。同样,不同的医疗保健系统和生存护理模式(例如,初级保健主导,患者主导等)会影响癌症患者的生存体验和结果。尽管西太平洋国家之间存在差异,但癌症幸存者面临的问题是相似的,面临着共同的挑战,包括缺乏对幸存者护理的关注,采用整体方法,以及劳动力的可用性。该地区正在制定和实施各种癌症幸存者方法,但需要一种全区域协调的方法,包括深思熟虑的领导和分享想法,以取得更好的结果。
{"title":"Cancer survivorship in the Western Pacific: from differences to shared-goals and from challenges to opportunities","authors":"Raymond Javan Chan ,&nbsp;Reegan Knowles ,&nbsp;Carolyn Taylor ,&nbsp;Nirmala Bhoo Pathy ,&nbsp;Ke Yu ,&nbsp;Karolina Lisy ,&nbsp;Julia Lai-Kwon ,&nbsp;Miyako Tsuchiya ,&nbsp;Yan Lou ,&nbsp;Wendy Lam ,&nbsp;Michael Jefford","doi":"10.1016/j.lanwpc.2025.101749","DOIUrl":"10.1016/j.lanwpc.2025.101749","url":null,"abstract":"<div><div>The Western Pacific region consists of 38 countries and approximately one quarter of the world population. Over 17 million people in the region have a personal history of cancer, necessitating effective survivorship care approaches for optimal outcomes and experiences. There are substantial differences in population and income and resource availability between countries within the region which impacts cancer survivorship care. Likewise, varying healthcare systems and models of survivorship care (e.g., primary care-led, patient-led etc.) affect the survivorship experience and outcome of people affected by cancer. Despite differences across Western Pacific countries, issues facing cancer survivors are similar, with shared challenges including lack of focus on survivorship care, adoption of a holistic approach, and workforce availability. Various approaches to cancer survivorship are being developed and implemented across the region, but a region-wide, coordinated approach is needed, involving thoughtful leadership and sharing of ideas to achieve better outcomes.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101749"},"PeriodicalIF":8.1,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145577834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Area-level socioeconomic status inequalities shape patterns of antimicrobial resistance in China, 2014–2023: a Bayesian spatiotemporal modelling analysis 2014-2023年中国地区社会经济地位不平等对抗菌素耐药性的影响:贝叶斯时空模型分析
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-11-13 DOI: 10.1016/j.lanwpc.2025.101745
Yi Yang , Jiani Jiang , Can Chen , Rongrong Qu , Yi Liu , Chen Xu , Xiangkun Zeng , Xiaofan Li , Yi Li , Weili Lin , Lili Huang , Mi Zhou , Mengsha Chen , Rong Zhang , Shigui Yang , Ning Dong

Background

Antimicrobial resistance (AMR) represents an escalating global health challenge, with socioeconomic status (SES) being a significant influencing factor. This study aimed to quantify area-level SES and assess its association with drug-resistant bacteria in China.

Methods

AMR data were collected from China Antimicrobial Resistance Surveillance System (CARSS, 2014–2023). Area-level SES across China was captured by County-level Area Deprivation Index (CADI) and Townsend Deprivation Index (TDI). Spatiotemporal distributions of drug-resistant bacteria were explored by spatial autocorrelation and spatiotemporal scan analyses. Key AMR risk factors were identified by GeoDetector analysis. Six Bayesian models were established through the Bayesian spatiotemporal modelling analysis. The Bayesian Spatiotemporal Interaction Hierarchy Model (BSTIHM), demonstrating superior estimative accuracy, was selected to forecast nationwide AMR patterns.

Findings

AMR profiles were obtained for totally 34,442,268 isolates of thirteen types of drug-resistant bacteria. The distributions of these bacteria exhibited manifest spatiotemporal heterogeneity nationwide. Both CADI and TDI consistently revealed a distinct socioeconomic gradient, with low area-level SES in western regions, medium in central regions, and high in eastern regions. Spatiotemporal clusters of drug-resistant bacteria were mainly observed in low SES regions. Lower area-level SES (odds ratio (OR) range: 1.054–1.254) and higher antimicrobial usage intensity (OR range: 1.022–1.174) contributed to higher risk of all thirteen types of drug-resistant bacteria. Meanwhile, total wastewater discharge (OR range: 1.064–1.280), PM2.5 (OR range: 1.031–1.135), and number of healthcare technicians per 10,000 people (OR range: 1.035–1.310) were correlated with risks of most drug-resistant bacteria. Estimated risks for all thirteen types of drug-resistant bacteria were increased in low and middle area-level SES regions based on the BSTIHM.

Interpretation

Area-level SES is a pivotal driver of AMR risk, which might be caused by antibiotic overuse and environmental pollution. Targeted investments in healthcare and environmental systems in lower area-level SES regions are essential to effectively reduce AMR burden.

Funding

National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, and Natural Science Foundation of Jiangsu Province.
抗生素耐药(AMR)是一个不断升级的全球健康挑战,社会经济地位(SES)是一个重要的影响因素。本研究旨在量化中国地区SES水平并评估其与耐药菌的关系。方法收集2014-2023年中国抗微生物药物耐药性监测系统(CARSS)的samr数据。采用县级区域剥夺指数(CADI)和汤森德剥夺指数(TDI)对全国区域级社会经济状况进行测度。通过空间自相关分析和时空扫描分析探讨耐药菌的时空分布。通过GeoDetector分析确定关键的AMR危险因素。通过贝叶斯时空建模分析,建立了6个贝叶斯模型。结果表明,贝叶斯时空相互作用层次模型(BSTIHM)具有较好的预测精度,可用于预测全国AMR格局。13种耐药菌共34,442,268株获得了samr谱。这些细菌在全国范围内的分布具有明显的时空异质性。CADI和TDI均表现出明显的社会经济梯度,西部低,中部中等,东部高。耐药菌的时空分布主要集中在低SES区域。较低的地区SES (OR范围:1.054 ~ 1.254)和较高的抗菌药物使用强度(OR范围:1.022 ~ 1.174)是13种耐药菌发生风险较高的因素。同时,污水排放总量(OR范围:1.064 ~ 1.280)、PM2.5 (OR范围:1.031 ~ 1.135)和每万人卫生技术人员(OR范围:1.035 ~ 1.310)与大多数耐药菌的风险相关。基于BSTIHM的13种耐药细菌的估计风险在中低区域SES区域均有所增加。区域SES是AMR风险的关键驱动因素,可能由抗生素过度使用和环境污染引起。有针对性地投资于社会经济地位较低地区的卫生保健和环境系统,对于有效减轻抗菌素耐药性负担至关重要。国家重点研发计划,国家自然科学基金,浙江省自然科学基金,江苏省自然科学基金。
{"title":"Area-level socioeconomic status inequalities shape patterns of antimicrobial resistance in China, 2014–2023: a Bayesian spatiotemporal modelling analysis","authors":"Yi Yang ,&nbsp;Jiani Jiang ,&nbsp;Can Chen ,&nbsp;Rongrong Qu ,&nbsp;Yi Liu ,&nbsp;Chen Xu ,&nbsp;Xiangkun Zeng ,&nbsp;Xiaofan Li ,&nbsp;Yi Li ,&nbsp;Weili Lin ,&nbsp;Lili Huang ,&nbsp;Mi Zhou ,&nbsp;Mengsha Chen ,&nbsp;Rong Zhang ,&nbsp;Shigui Yang ,&nbsp;Ning Dong","doi":"10.1016/j.lanwpc.2025.101745","DOIUrl":"10.1016/j.lanwpc.2025.101745","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) represents an escalating global health challenge, with socioeconomic status (SES) being a significant influencing factor. This study aimed to quantify area-level SES and assess its association with drug-resistant bacteria in China.</div></div><div><h3>Methods</h3><div>AMR data were collected from China Antimicrobial Resistance Surveillance System (CARSS, 2014–2023). Area-level SES across China was captured by County-level Area Deprivation Index (CADI) and Townsend Deprivation Index (TDI). Spatiotemporal distributions of drug-resistant bacteria were explored by spatial autocorrelation and spatiotemporal scan analyses. Key AMR risk factors were identified by GeoDetector analysis. Six Bayesian models were established through the Bayesian spatiotemporal modelling analysis. The Bayesian Spatiotemporal Interaction Hierarchy Model (BSTIHM), demonstrating superior estimative accuracy, was selected to forecast nationwide AMR patterns.</div></div><div><h3>Findings</h3><div>AMR profiles were obtained for totally 34,442,268 isolates of thirteen types of drug-resistant bacteria. The distributions of these bacteria exhibited manifest spatiotemporal heterogeneity nationwide. Both CADI and TDI consistently revealed a distinct socioeconomic gradient, with low area-level SES in western regions, medium in central regions, and high in eastern regions. Spatiotemporal clusters of drug-resistant bacteria were mainly observed in low SES regions. Lower area-level SES (odds ratio (OR) range: 1.054–1.254) and higher antimicrobial usage intensity (OR range: 1.022–1.174) contributed to higher risk of all thirteen types of drug-resistant bacteria. Meanwhile, total wastewater discharge (OR range: 1.064–1.280), PM<sub>2.5</sub> (OR range: 1.031–1.135), and number of healthcare technicians per 10,000 people (OR range: 1.035–1.310) were correlated with risks of most drug-resistant bacteria. Estimated risks for all thirteen types of drug-resistant bacteria were increased in low and middle area-level SES regions based on the BSTIHM.</div></div><div><h3>Interpretation</h3><div>Area-level SES is a pivotal driver of AMR risk, which might be caused by antibiotic overuse and environmental pollution. Targeted investments in healthcare and environmental systems in lower area-level SES regions are essential to effectively reduce AMR burden.</div></div><div><h3>Funding</h3><div>National Key R&amp;D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, and Natural Science Foundation of Jiangsu Province.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"65 ","pages":"Article 101745"},"PeriodicalIF":8.1,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1